Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Dermatologic Agents"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 409
Tytuł:
Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists.
Autorzy:
Mahé E; Dermatology Department, Hôpital Victor Dupouy, Argenteuil, France.
Beauchet A; Public Health Department, Centre Hospitalier Universitaire Ambroise Paré, Boulogne-Billancourt, France.
Hadj-Rabia S; Dermatology Department, INSERM U1163 & Institut Imagine, Centre Hospitalier Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes - Sorbonne, Paris, France.
Mazereeuw-Hautier J; Dermatology Department, Centre de Référence des Maladies Rares de la Peau et des Muqueuses, Hôpital Larrey, Toulouse, France.
Mallet S; Dermatology Department, Hôpital de la Timone, Assistance-Publique-Hôpitaux de Marseille, Marseille, France.
Phan A; Paediatric Department, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Bron, France.
Severino-Freire M; Dermatology Department, Centre de Référence des Maladies Rares de la Peau et des Muqueuses, Hôpital Larrey, Toulouse, France.
Boralevi F; Department of Paediatric Dermatology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
Aubert H; Dermatology Department, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Barthélémy H; Dermatology Department, Centre Hospitalier d'Auxerre, Auxerre, France.
Girard C; Dermatology Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Martin L; Dermatology Department, Centre Hospitalier Universitaire d'Angers, Angers, France.
Piram M; Service de Rhumatologie Pédiatrique, Centre Hospitalier Universitaire Bicêtre, Université Paris Sud-Saclay, UVSQ, Assistance Publique-Hôpitaux de Paris HP, Le Kremlin Bicêtre, France.
Barbarot S; Dermatology Department, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Balguerie X; Dermatology Department, Centre Hospitalier Universitaire Charles-Nicolle, Rouen, France.
Zitouni J; Dermatology Department, Hôpital Victor Dupouy, Argenteuil, France.
Phan C; Dermatology Department, Hôpital Victor Dupouy, Argenteuil, France.
Di Lernia V; Dermatology Unit, Arcispedale S. Maria Nuova IRCCS, Reggio Emilia, Italy.
Pokaż więcej
Corporate Authors:
Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD), Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.)
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15828. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article
MeSH Terms:
Biological Products*/adverse effects
Biological Products*/therapeutic use
Dermatologic Agents*/adverse effects
Dermatologic Agents*/therapeutic use
Psoriasis*/drug therapy
Child ; Humans ; Acitretin/adverse effects ; Acitretin/therapeutic use ; Adalimumab/adverse effects ; Adalimumab/therapeutic use ; Dermatologists ; Etanercept/adverse effects ; Etanercept/therapeutic use ; Methotrexate/adverse effects ; Methotrexate/therapeutic use ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/adverse effects ; Tumor Necrosis Factor Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.
Autorzy:
Nofal A; Dermatology Department, School of Medicine, Zagazig University, Zagazig, Egypt.; Member of Interactive Dermatology Research Group, Cairo, Egypt.
Fawzy MM; Member of Interactive Dermatology Research Group, Cairo, Egypt.; Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Eldeeb F; Dermatology Department, School of Medicine, Zagazig University, Zagazig, Egypt.; Member of Interactive Dermatology Research Group, Cairo, Egypt.
Nofal H; Dermatology Department, School of Medicine, Zagazig University, Zagazig, Egypt.
El-Hawary EE; Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15964. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Dermatologic Agents*
Condylomata Acuminata*/diagnosis
Condylomata Acuminata*/drug therapy
Warts*/diagnosis
Warts*/drug therapy
Humans ; Isotretinoin ; Administration, Oral ; Papillomaviridae
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.
Autorzy:
Kassem B; Department of Dermatology, Tishreen University, Lattakia, Syria.
Ismail M; Department of Dermatology, Tishreen University, Lattakia, Syria.
Hassan F; Department of Dermatology, Tishreen University, Lattakia, Syria.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15974. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Dermatologic Agents*
Acne Vulgaris*/diagnosis
Acne Vulgaris*/drug therapy
Acne Vulgaris*/chemically induced
Drug-Related Side Effects and Adverse Reactions*
Humans ; Young Adult ; Adult ; Isotretinoin ; Treatment Outcome ; Recurrence ; Clinical Protocols ; Chronic Disease ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease-A hybrid trial using a smartphone application, optical coherence tomography, and patient-reported outcome measures.
Autorzy:
Ortner VK; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.; LEO Pharma A/S, Ballerup, Denmark.
Mandel VD; Dermatology Unit, Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.; Porphyria and Rare Diseases Unit, San Gallicano Dermatological Institute - IRCCS, Rome, Italy.
Skak K; LEO Pharma A/S, Ballerup, Denmark.
Zibert JR; Future-Brain Aps, Copenhagen, Denmark.
Bourlioux M; Omhu A/S, LEO Innovation Lab, Copenhagen, Denmark.
Nissen CV; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Fuchs CSK; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Philipsen PA; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Haedersdal M; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15965. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Dermatologic Agents*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Mobile Applications*
Nail Diseases*/diagnosis
Nail Diseases*/drug therapy
Humans ; Tomography, Optical Coherence ; Smartphone ; Aerosols ; Betamethasone ; Patient Reported Outcome Measures ; Treatment Outcome ; Lasers ; Drug Combinations
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis.
Autorzy:
Gallo G; Dermatology Clinic, Department of medical sciences, University of Turin, Turin, Italy.
Mastorino L; Dermatology Clinic, Department of medical sciences, University of Turin, Turin, Italy.
Barilà D; Department of Pharmaceutical Science and Technology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Cattel F; Department of Pharmaceutical Science and Technology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Panzone M; Dermatology Clinic, Department of medical sciences, University of Turin, Turin, Italy.
Quaglino P; Dermatology Clinic, Department of medical sciences, University of Turin, Turin, Italy.
Ribero S; Dermatology Clinic, Department of medical sciences, University of Turin, Turin, Italy.
Dapavo P; Dermatology Clinic, Department of medical sciences, University of Turin, Turin, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15917. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*
Nail Diseases*/diagnosis
Nail Diseases*/drug therapy
Nail Diseases*/etiology
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/complications
Humans ; Cyclosporine ; Ointments/therapeutic use ; Prospective Studies ; Hydrogels/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience.
Autorzy:
Gönülal M; Unit of Dermatology, İzmir Tepecik Training and Research Hospital, University of Health Sciences, İzmir, Turkey.
Altunay İK; Unit of Dermatology, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Doğan S; Unit of Dermatology, Çiğli Regional Education Hospital, Bakırçay University, İzmir, Turkey.
Türkmen M; Unit of Dermatology, İzmir Bozyaka Training and Research Hospital, University of Health Sciences, İzmir, Turkey.
Balcı DD; Unit of Dermatology, İzmir Tepecik Training and Research Hospital, University of Health Sciences, İzmir, Turkey.
Öztürkcan S; Unit of Dermatology, Manisa Celal Bayar University Hafsa Sultan Hospital, Manisa, Turkey.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15955. Date of Electronic Publication: 2022 Oct 31.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/chemically induced
Humans ; Male ; Female ; Antibodies, Monoclonal, Humanized/adverse effects ; Treatment Outcome ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case-control study.
Autorzy:
Chou YJ; Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Wu CY; Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.; College of Public Health, China Medical University, Taichung, Taiwan.
Pan TY; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Wu CY; Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Public Health and Department of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Department of Dermatology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chang YT; Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.; Department of Dermatology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15804. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/complications
Biological Products*/adverse effects
Neoplasms*/chemically induced
Neoplasms*/drug therapy
Neoplasms*/epidemiology
Dermatologic Agents*
Humans ; Case-Control Studies ; Ustekinumab/therapeutic use ; Etanercept/therapeutic use ; Adalimumab/therapeutic use ; Methotrexate/adverse effects ; Cyclosporine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ixekizumab treatment for drug-induced erythrodermic psoriasis.
Autorzy:
Pinto-Pulido EL; Department of Dermatology, Hospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain.
Polo-Rodríguez I; Department of Dermatology, Hospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain.
González-Cañete M; Department of Dermatology, Hospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain.
García-Verdú E; Department of Dermatology, Hospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain.
Piteiro-Bermejo AB; Department of Dermatology, Hospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain.
Medina-Montalvo S; Department of Dermatology, Hospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15863. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Letter
MeSH Terms:
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Dermatologic Agents*/adverse effects
Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Treatment Outcome ; Severity of Illness Index
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris.
Autorzy:
Fazelzadeh Haghighi N; Molecular Dermatology Research Center & Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.
Dastgheib L; Molecular Dermatology Research Center & Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.
Saki N; Molecular Dermatology Research Center & Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.
Alipour S; Department of Quality Control, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Ranjbar S; Molecular Dermatology Research Center & Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Oct; Vol. 35 (10), pp. e15770. Date of Electronic Publication: 2022 Aug 29.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Acne Vulgaris*/pathology
Dermatologic Agents*
Acetates ; Anti-Bacterial Agents ; Benzoyl Peroxide ; Cyclopropanes ; Double-Blind Method ; Doxycycline/therapeutic use ; Gels/therapeutic use ; Humans ; Immunoglobulin A/therapeutic use ; Leukotriene B4/therapeutic use ; Quinolines ; Sulfides ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acne care in health care providers during the COVID-19 pandemic: A national survey.
Autorzy:
Cretu S; Pediatric Dermatology Department, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; Dermatology Research Unit, Colentina Clinical Hospital, Bucharest, Romania.
Dascalu M; Department of Computer Science, Polytechnic University of Bucharest, Bucharest, Romania.
Salavastru CM; Pediatric Dermatology Department, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; Pediatric Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Oct; Vol. 35 (10), pp. e15753. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
Acne Vulgaris*/chemically induced
Acne Vulgaris*/epidemiology
Acne Vulgaris*/therapy
COVID-19*/epidemiology
Dermatologic Agents*
Anti-Bacterial Agents ; Benzoyl Peroxide ; Cross-Sectional Studies ; Health Personnel ; Humans ; Pandemics ; Retinoids ; Salicylic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Calcipotriol: A novel tool in treatment of acne vulgaris.
Autorzy:
Abdel-Wahab HM; Department of Dermatology, Faculty of Medicine, Minia University, Al Minya, Egypt.
Ali AK; Department of Dermatology, Faculty of Medicine, Minia University, Al Minya, Egypt.
Ragaie MH; Department of Dermatology, Faculty of Medicine, Minia University, Al Minya, Egypt.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Sep; Vol. 35 (9), pp. e15690. Date of Electronic Publication: 2022 Jul 13.
Typ publikacji:
Journal Article
MeSH Terms:
Acne Vulgaris*/diagnosis
Acne Vulgaris*/drug therapy
Acne Vulgaris*/pathology
Dermatologic Agents*
Adapalene ; Anti-Inflammatory Agents/therapeutic use ; Calcitriol/analogs & derivatives ; Gels/therapeutic use ; Humans ; Prospective Studies ; Retinoids ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of safety and efficacy of topical 4% nicotinamide in treatment of psoriasis; among a representative sample of Egyptians (an analytical observational study).
Autorzy:
El-Khalawany M; Department of Dermatology and Venereology, Faculty of Medicine, Al Azhar University, Cairo, Egypt.
Nouh AH; Department of Dermatology and Venereology, Faculty of Medicine, Al Azhar University, Cairo, Egypt.
Kadah AS; Department of Dermatology and Venereology, Faculty of Medicine, Al-Hussin University Hospital, Al-Azhar University, Cairo, Egypt.
Elsheikh M; Department of Dermatology and Venereology, Military Medical Academy, Cairo, Egypt.
Said M; Department of Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Sep; Vol. 35 (9), pp. e15734. Date of Electronic Publication: 2022 Aug 03.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Dermatologic Agents*
Psoriasis*/chemically induced
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Administration, Topical ; Egypt ; Emollients/therapeutic use ; Female ; Humans ; Male ; Niacinamide/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study.
Autorzy:
Abdelmeniem IM; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
El Eryan IM; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Nofal A; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Fouda I; Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Omar SS; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Sep; Vol. 35 (9), pp. e15660. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Dermatologic Agents*
Nail Diseases*/diagnosis
Nail Diseases*/drug therapy
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Calcitriol/analogs & derivatives ; Fluorouracil/adverse effects ; Humans ; Injections, Intralesional ; Methotrexate ; Treatment Outcome ; Triamcinolone Acetonide/adverse effects ; Urea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acne treatment review and future perspectives.
Autorzy:
Mohsin N; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Hernandez LE; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Martin MR; Colgate University, Hamilton, New York, USA.
Does AV; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Nouri K; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Sep; Vol. 35 (9), pp. e15719. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Acne Vulgaris*/diagnosis
Acne Vulgaris*/drug therapy
Dermatologic Agents*/therapeutic use
Anti-Bacterial Agents/therapeutic use ; Benzoyl Peroxide/therapeutic use ; Humans ; Isotretinoin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis).
Autorzy:
Malagoli P; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.
Dapavo P; Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.
Pavia G; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Amoruso F; Dermatology Unit, Azienda Ospedaliera di Cosenza, Italy.
Argenziano G; Department of Dermatology, 'Luigi Vanvitelli' University School of Medicine, Naples, Italy.
Bardazzi F; Dermatology Unit, Department of Specialistic, Diagnostic and Experimental Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Burlando M; Section of Dermatology, Department of Health Sciences (DISSAL), IRCCS San Martino University Hospital, Genoa, Italy.
Carrera CG; Fondazione Cà Granda IRCCS Maggiore Policlinico Hospital, Milan, Italy.
Damiani G; Clinical Dermatology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milan, Italy.
Dini V; Dermatology Unit, Department of Clinical and Experimental Medicine Ospedale Santa Chiara, Pisa, Italy.
Girolomoni G; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Guarneri C; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Loconsole F; Department of Dermatology, University of Bari, Bari, Italy.
Narcisi A; Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Sampogna F; Istituto Dermopatico Dell'Immacolata, (IDI) IRCCS, Rome, Italy.
Travaglini M; U.O.S.D. Dermatologica, Centro per la cura della psoriasi, Ospedale Perrino, Brindisi, Italy.
Costanzo A; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Aug; Vol. 35 (8), pp. e15608. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Antibodies, Monoclonal, Humanized*/therapeutic use
Dermatologic Agents*/therapeutic use
Psoriasis*/drug therapy
Humans ; Interleukin-17 ; Quality of Life ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis.
Autorzy:
Suehiro M; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Numata T; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Murakami E; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takahashi M; Graduate School of Innovation and Technology Management, Yamaguchi University, Yamaguchi, Japan.
Saito R; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Morioke S; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kamegashira A; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takahagi S; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Hide M; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tanaka A; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jul; Vol. 35 (7), pp. e15526. Date of Electronic Publication: 2022 Apr 23.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatitis, Atopic*/diagnosis
Dermatitis, Atopic*/drug therapy
Dermatologic Agents*/adverse effects
Adult ; Emollients ; Glucocorticoids ; Humans ; Ointments ; Pyrroles ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross-sectional study.
Autorzy:
Nasimi M; Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Abedini R; Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ghandi N; Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hajinamaki H; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hasan Zadeh Tabatabaei MS; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ansari MS; Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jul; Vol. 35 (7), pp. e15547. Date of Electronic Publication: 2022 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Administration, Topical ; Cross-Sectional Studies ; Humans ; Medication Adherence ; Treatment Adherence and Compliance
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The safety and efficacy of a novel topical cosmeceutical compound combined with oral isotretinoin and laser treatments for active acne and acne scarring.
Autorzy:
Nazarali S; Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Pantaleon A; Derma Skin Institute, Guelph, Ontario, Canada.
Sajic S; Derma Skin Institute, Guelph, Ontario, Canada.
Sajic D; Derma Skin Institute, Guelph, Ontario, Canada.; Faculty of Health Sciences, McMaster University, Waterloo, Ontario, Canada.; Guelph Dermatology Research, Guelph, Ontario, Canada.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jul; Vol. 35 (7), pp. e15512. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji:
Letter
MeSH Terms:
Acne Vulgaris*/drug therapy
Cosmeceuticals*/therapeutic use
Dermatologic Agents*
Administration, Oral ; Cicatrix/therapy ; Humans ; Isotretinoin ; Lasers ; Treatment Outcome
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The association topical antifungals/topical corticosteroids in superficial mycoses of the skin: A critical review of the literature and personal experience.
Autorzy:
Veraldi S; Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Bortoluzzi P; Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jun; Vol. 35 (6), pp. e15487. Date of Electronic Publication: 2022 Apr 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Dermatologic Agents*/therapeutic use
Dermatomycoses*/diagnosis
Dermatomycoses*/drug therapy
Humans ; Administration, Topical ; Adrenal Cortex Hormones/therapeutic use ; Antifungal Agents/therapeutic use ; Skin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sub-population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population.
Autorzy:
Rigopoulos D; 1st Department of Dermatology-Venereology, University of Athens, Athens, Greece.
Lazaridou E; 2nd Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, Greece.
Papadavid E; 2nd Department of Dermatology and Venereology, ATTIKON University Hospital, Athens, Greece.
Georgiou S; Department of Dermatology, Medical School, General University Hospital, University of Patras, Rio, Greece.
Chasapi V; Department of Dermatology and Venereology NHS, Andreas Syggros Hospital, Athens, Greece.
Sfaelos K; Dermatology, LEO Pharma Hellas, Kifissia, Greece.
Cheliotis G; Health Data Specialists S.A., Athina, Greece.
Ioannides D; First Department of Dermatology-Venereology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Jun; Vol. 35 (6), pp. e15484. Date of Electronic Publication: 2022 May 09.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*
Psoriasis*/complications
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Humans ; Aerosols ; Betamethasone ; Calcitriol/analogs & derivatives ; Drug Combinations ; Greece ; Patient Satisfaction ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 409

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies